
Adline Chem Lab Ltd is Rated Strong Sell
2025-12-26 21:51:26Adline Chem Lab Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Mar 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 26 December 2025, providing investors with the latest perspective on its fundamentals, valuation, financial trends, and technical signals.
Read full news article
Adline Chem Lab Sees Revision in Market Evaluation Amidst Challenging Performance
2025-12-11 10:10:04Adline Chem Lab, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation metrics. This shift reflects a reassessment of the company’s fundamentals and market position amid sustained stock price declines and sector challenges.
Read full news article
Adline Chem Lab Falls to 52-Week Low of Rs.7.6 Amidst Market Pressure
2025-12-03 11:15:32Adline Chem Lab has reached a new 52-week low of Rs.7.6, marking a significant decline in its stock price amid broader market fluctuations and sector-specific pressures. The stock’s recent performance highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, with the company’s shares underperforming both the sector and key market indices.
Read full news article
Adline Chem Lab Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-12-03 10:40:14Adline Chem Lab Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of recent price volatility and subdued sector performance.
Read full news article
Adline Chem Lab Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-03 10:35:22Adline Chem Lab Ltd has encountered significant selling pressure, with the stock hitting a new 52-week low of Rs.7.6 today. The pharmaceutical and biotechnology company’s shares have experienced consecutive declines, reflecting distress selling and a lack of buyer interest in the current market environment.
Read full news article
Adline Chem Lab Falls to 52-Week Low of Rs.8 Amidst Market Pressure
2025-12-02 15:50:22Adline Chem Lab has reached a new 52-week low of Rs.8, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The pharmaceutical and biotechnology company’s shares have experienced notable downward pressure, reflecting a challenging period for the stock.
Read full news article
Adline Chem Lab Stock Falls to 52-Week Low of Rs.8 Amidst Market Pressure
2025-12-02 15:50:21Adline Chem Lab, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.8, marking a significant decline in its stock price amid broader market fluctuations and company-specific factors.
Read full news article
Adline Chem Lab Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
2025-12-02 11:16:32Adline Chem Lab Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market behaviour suggests a potential multi-day circuit scenario, reflecting intense demand despite recent price volatility and sector underperformance.
Read full news article
Adline Chem Lab Falls to 52-Week Low of Rs.8.4 Amidst Continued Downtrend
2025-11-28 15:41:35Adline Chem Lab, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.8.4, marking a significant decline in its stock price amid a sustained downward trend over recent sessions.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECompliance Certificate under Reg. 74 (5) of SEBI (DP) Regulation 2018
Closure of Trading Window
30-Dec-2025 | Source : BSEClosure of Trading Window
Fresh Corporate Announcement For The Earlier Corporate Announcement Submitted Dated 13Th June 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
30-Dec-2025 | Source : BSESubmitting of the additional information regarding reason for resignation of Chief Financial Officer(CFO) of the Company.
Corporate Actions
10 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






